129 related articles for article (PubMed ID: 8921832)
1. Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat.
Torsello A; Grilli R; Luoni M; Guidi M; Ghigo MC; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
Eur J Endocrinol; 1996 Oct; 135(4):481-8. PubMed ID: 8921832
[TBL] [Abstract][Full Text] [Related]
2. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
Torsello A; Luoni M; Grilli R; Guidi M; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
[TBL] [Abstract][Full Text] [Related]
3. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
[TBL] [Abstract][Full Text] [Related]
5. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
6. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE
Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930
[TBL] [Abstract][Full Text] [Related]
8. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone.
Conley LK; Brogan RS; Giustina A; Wehrenberg WB
Pituitary; 2000 May; 2(4):253-60. PubMed ID: 11081146
[TBL] [Abstract][Full Text] [Related]
9. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
10. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
13. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
Maccario M; Arvat E; Procopio M; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
Metabolism; 1995 Jan; 44(1):134-8. PubMed ID: 7854159
[TBL] [Abstract][Full Text] [Related]
14. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
[TBL] [Abstract][Full Text] [Related]
15. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
Giustina A; Desenzani P; Perini P; Deghenghi R; Bugari G; Wehrenberg WB; Giustina G
Endocr Res; 1996 May; 22(2):159-74. PubMed ID: 8799695
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
Conley LK; Teik JA; Deghenghi R; Imbimbo BP; Giustina A; Locatelli V; Wehrenberg WB
Neuroendocrinology; 1995 Jan; 61(1):44-50. PubMed ID: 7731497
[TBL] [Abstract][Full Text] [Related]
18. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?
Roh SG; Chen C; Choi KC; Shrestha Y; Sasaki S
Endocrinology; 2002 May; 143(5):1964-7. PubMed ID: 11956179
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
[TBL] [Abstract][Full Text] [Related]
20. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
